A new grant to validate FGL2-based technologies
Veritas receives an operating grant to validate FGL2-based technologies for treatment of chronic viral infections. The study will confirm the utility of FGL2 technologies in patients with chronic viral infections. The results of these clinical studies will have broader implications for other immune-mediated disease including autoimmunity, transplant rejection and cancer.
Veritas enters into new collaborative license agreement to commercialize technologies
Veritas enters into a new collaborative license agreement to commercialize technologies related to development diagnostic applications for treatment of patient with transplant rejection.
FGL2 as a biomarker for tolerance induction in the setting of transplantation
A new report published in the Liver Transplantation Journal demonstrates the ability to use FGL2 expression as a biomarker for tolerance induction in transplantation. The study shows that FGL2 expression is asscoiated to the development of tolerance of liver and cardiac allografts in an experimental model of transplant rejection and tolerance. The results of the study suggest the FGL2 levels may sever as a biomarker for development of autoimmune diseases including arthritis, diabetes, and inflammatory bowel disease.
Veritas enters into commercial development agreement with FZMB
Veritas enters into Commercial Development Agreement with FZMB to commercialize the ABICAP technologies. The company fzmb GmbH was founded in 1994. They are active in research and realization of innovative services since 1995 and on the Canadian Market since 2001. fzmb GmbH employs 93 people from different branches in interdisciplinary research teams of Physicists, engineers, doctors, chemists, biologists, technicians and nurses and veterinary clinic.
Veritas enters into license agreement with BioLegend
Veritas enters into license agreement with BioLegend to commercialize Mouse FGL2 ELISA kits for research diagnostic usage. Under this agreement BioLegend will sell the mouse FGL2 ELISA kits worldwide for research usage only.